Editor-in-Chief
British Journal of Clinical Pharmacology
June 03, 2020
I am pleased to submit an original research article entitled “Drugs-Induced QT Interval Prolongation among End Stage Renal Disease Patients in Jordan”
In spite of high risk of deadly complications due to drug-induced QT interval prolongation usage among end stage renal disease patients, no previous studies were conducted to assess medication safety of this drugs category among this vulnerable patients group.
In this manuscript, we show that Major drug-drug interactions and dispensing medications with risk of developing QT interval prolongation based on inappropriate prescribing decisions for patients with end stage renal disease were reported to be high in outpatient clinics in Jordan. Therefore, proper pharmaceutical care should be improved to intervene on this events and maintain patient safety.We believe that this manuscript is appropriate for publication by The British Journal of Clinical Pharmacology because it links to the Journal’s aims and scope. This manuscript has not been published and is not under consideration for publication elsewhere. We have no conflicts of interest to disclose.
Thank you for your consideration!
Dania Abu-Naser
Al Balqa Applied University, Jordan